No significant weaknesses identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| BRK-BBerkshire Hathaway Inc. | 676.28B | 492.62 | 11.94 | -15.46% | 17.82% | 9.6% | 1.72% | 0.22 |
| BRK-ABerkshire Hathaway Inc. | 386.34B | 738691.00 | 11.93 | 1.24% | 17.95% | 9.63% | 3.01% | 0.20 |
| AIGAmerican International Group, Inc. | 39.94B | 74.03 | -34.12 | -2.46% | 11.9% | 7.93% | 8.19% | 0.21 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 210.94B | 223.42B | 242.06B | 225.38B | 327.22B | 286.32B | 354.73B | 234.12B | 439.34B | 371.43B |
| Revenue Growth % | 0.08% | 0.06% | 0.08% | -0.07% | 0.45% | -0.12% | 0.24% | -0.34% | 0.88% | -0.15% |
| Medical Costs & Claims | 118.97B | 133.9B | 158.85B | 151.69B | 156.48B | 150.85B | 169.93B | 187.21B | 230.5B | 284.86B |
| Medical Cost Ratio % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 91.97B | 89.51B | 83.21B | 73.69B | 170.74B | 135.47B | 184.8B | 46.91B | 208.84B | 86.58B |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 0.09% | -0.03% | -0.07% | -0.11% | 1.32% | -0.21% | 0.36% | -0.75% | 3.45% | -0.59% |
| Operating Expenses | 57.03B | 55.85B | 59.37B | 69.69B | 68.04B | 79.78B | 72.94B | 77.41B | 88.67B | 27.14B |
| OpEx / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | 7.78B | 8.9B | 9.19B | 9.78B | 10.06B | 10.6B | 10.72B | 10.9B | 12.49B | 12.86B |
| Combined Ratio % | - | - | - | - | - | - | - | - | - | - |
| Operating Income | 34.95B | 33.67B | 23.84B | 4B | 102.7B | 55.69B | 111.86B | -30.5B | 120.17B | 59.44B |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 0.24% | -0.04% | -0.29% | -0.83% | 24.67% | -0.46% | 1.01% | -1.27% | 4.94% | -0.51% |
| EBITDA | 42.73B | 42.57B | 33.03B | 13.78B | 112.76B | 66.29B | 122.58B | -19.6B | 132.65B | 72.29B |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | 3.52B | 3.74B | 4.39B | 3.85B | 3.96B | 4.08B | 4.17B | 4.35B | 5B | 5.2B |
| Non-Operating Income | -3.52B | -3.74B | -4.39B | -3.85B | -3.96B | -4.08B | -4.17B | -4.35B | -5B | -56.14B |
| Pretax Income | 34.95B | 33.67B | 23.84B | 4B | 102.7B | 55.69B | 111.86B | -30.5B | 120.17B | 110.38B |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 10.53B | 9.24B | -21.52B | -321M | 20.9B | 12.44B | 20.91B | -8.5B | 23.02B | 20.82B |
| Effective Tax Rate % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 24.08B | 24.07B | 44.94B | 4.02B | 81.42B | 42.52B | 89.94B | -22.76B | 96.22B | 89B |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 0.21% | -0% | 0.87% | -0.91% | 19.25% | -0.48% | 1.12% | -1.25% | 5.23% | -0.08% |
| EPS (Diluted) | 9.77 | 9.76 | 18.22 | 1.63 | 33.22 | 17.78 | 39.64 | -10.36 | 44.27 | 41.27 |
| EPS Growth % | 0.21% | -0% | 0.87% | -0.91% | 19.38% | -0.46% | 1.23% | -1.26% | 5.27% | -0.07% |
| EPS (Basic) | 9.77 | 9.76 | 18.22 | 1.63 | 33.22 | 17.78 | 39.64 | -10.36 | 44.27 | 41.27 |
| Diluted Shares Outstanding | 2.46B | 2.47B | 2.47B | 2.47B | 2.45B | 2.39B | 2.27B | 2.2B | 2.17B | 2.16B |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 552.26B | 620.85B | 702.1B | 707.79B | 817.73B | 873.73B | 958.78B | 948.47B | 1.07T | 1.15T |
| Asset Growth % | 0.05% | 0.12% | 0.13% | 0.01% | 0.16% | 0.07% | 0.1% | -0.01% | 0.13% | 0.08% |
| Total Investment Assets | 187.66B | 236.56B | 298.06B | 292.11B | 348.64B | 409.86B | 443.91B | 455.92B | 537.24B | 605.41B |
| Long-Term Investments | 183.09B | 178.24B | 213.69B | 210.6B | 284.82B | 319.56B | 385.38B | 363.15B | 407.62B | 318.93B |
| Short-Term Investments | 4.57B | 58.32B | 84.37B | 81.51B | 63.82B | 90.3B | 58.53B | 92.77B | 129.62B | 286.47B |
| Total Current Assets | 119.72B | 142.49B | 179.99B | 182.45B | 201.21B | 212.55B | 227.99B | 225.44B | 267.74B | 434.4B |
| Cash & Equivalents | 67.16B | 28.05B | 31.58B | 30.36B | 64.17B | 47.99B | 88.18B | 35.81B | 38.02B | 47.73B |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill & Intangibles | 72.5B | 113.57B | 114.44B | 113.17B | 113.53B | 104.42B | 103.51B | 108.6B | 121.77B | 119.65B |
| Goodwill | 62.71B | 79.49B | 81.26B | 81.03B | 81.88B | 73.73B | 73.88B | 78.12B | 84.63B | 83.88B |
| Intangible Assets | 9.8B | 34.09B | 33.18B | 32.15B | 31.65B | 30.68B | 29.64B | 30.48B | 37.14B | 35.77B |
| PP&E (Net) | 145.17B | 152.77B | 158.22B | 166.71B | 180.28B | 192.6B | 196.37B | 201.94B | 221.87B | 228.77B |
| Other Assets | 29.11B | 30.42B | 32.46B | 32.76B | -28.91B | -29.49B | -44.71B | -27.68B | -42.03B | 52.12B |
| Total Liabilities | 293.63B | 335.43B | 350.14B | 355.29B | 389.17B | 422.39B | 443.85B | 466.78B | 499.21B | 502.23B |
| Total Debt | 72.34B | 86.26B | 102.59B | 97.49B | 109.25B | 122.36B | 119.25B | 127.68B | 133.57B | 143.53B |
| Net Debt | 5.18B | 58.21B | 71B | 67.13B | 45.08B | 74.37B | 31.07B | 91.87B | 95.55B | 95.8B |
| Long-Term Debt | 82.3B | 91.39B | 96.27B | 85.28B | 92.95B | 107.5B | 108.12B | 109.78B | 114.41B | 115.4B |
| Short-Term Debt | 1.99B | 10.26B | 6.32B | 12.21B | 11.79B | 10.74B | 7.38B | 14.24B | 15.28B | 23.63B |
| Total Current Liabilities | 33.02B | 45.15B | 42.14B | 49.29B | 48.16B | 49.65B | 48.08B | 58.88B | 64.63B | 73.11B |
| Accounts Payable | 31.03B | 33.45B | 35.82B | 37.08B | 36.36B | 38.91B | 40.7B | 44.63B | 49.35B | 49.48B |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 1000K | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Liabilities | 101.87B | 210.25B | 139.09B | 151.26B | 156.97B | 165.62B | 170.14B | 188.44B | 192.77B | 192.54B |
| Total Equity | 258.63B | 285.43B | 351.95B | 352.5B | 428.56B | 451.34B | 514.93B | 481.68B | 570.77B | 651.65B |
| Equity Growth % | 0.06% | 0.1% | 0.23% | 0% | 0.22% | 0.05% | 0.14% | -0.06% | 0.18% | 0.14% |
| Shareholders Equity | 255.55B | 282.07B | 348.3B | 348.7B | 424.79B | 443.16B | 506.2B | 473.42B | 561.27B | 649.37B |
| Minority Interest | 3.08B | 3.36B | 3.66B | 3.8B | 3.77B | 8.17B | 8.73B | 8.26B | 9.5B | 2.29B |
| Retained Earnings | 187.7B | 210.85B | 255.79B | 321.11B | 402.49B | 444.63B | 534.42B | 511.13B | 607.35B | 696.22B |
| Common Stock | 8M | 8M | 8M | 8M | 8M | 8M | 8M | 8M | 8M | 8M |
| Accumulated OCI | 33.98B | 37.3B | 58.57B | -5.01B | -5.24B | -4.24B | -4.03B | -5.05B | -3.76B | -3.58B |
| Return on Equity (ROE) | 0.1% | 0.09% | 0.14% | 0.01% | 0.21% | 0.1% | 0.19% | -0.05% | 0.18% | 0.15% |
| Return on Assets (ROA) | 0.04% | 0.04% | 0.07% | 0.01% | 0.11% | 0.05% | 0.1% | -0.02% | 0.1% | 0.08% |
| Equity / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / Equity | 0.28x | 0.30x | 0.29x | 0.28x | 0.25x | 0.27x | 0.23x | 0.27x | 0.23x | 0.22x |
| Book Value per Share | 104.93 | 115.76 | 142.67 | 142.96 | 174.86 | 188.71 | 227.32 | 218.62 | 262.63 | 302.17 |
| Tangible BV per Share | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 31.49B | 32.53B | 45.78B | 37.4B | 38.69B | 39.77B | 39.42B | 37.22B | 49.2B | 30.59B |
| Operating CF Growth % | -0.02% | 0.03% | 0.41% | -0.18% | 0.03% | 0.03% | -0.01% | -0.06% | 0.32% | -0.38% |
| Operating CF / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 24.41B | 24.43B | 45.35B | 4.32B | 81.79B | 43.25B | 90.81B | -22.06B | 97.15B | 89.56B |
| Depreciation & Amortization | 7.78B | 8.9B | 9.19B | 9.78B | 10.06B | 10.6B | 10.72B | 10.9B | 12.49B | 12.86B |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -8.62B | -7.71B | -952M | 25.11B | -72.38B | -29.64B | -80.97B | 63.3B | -80.88B | -65.04B |
| Working Capital Changes | 7.92B | 6.92B | -7.81B | -1.81B | 19.21B | 15.57B | 18.87B | -14.92B | 20.44B | -6.78B |
| Cash from Investing | -26.67B | -84.27B | -41.09B | -32.85B | -5.62B | -37.76B | 29.39B | -87.6B | -32.66B | -10.29B |
| Capital Expenditures | -16.08B | -12.95B | -11.71B | -14.54B | -15.98B | -13.01B | -13.28B | -15.46B | -19.41B | -18.98B |
| Acquisitions | -4.9B | -31.4B | -2.71B | -3.28B | -1.68B | -2.53B | -456M | -10.59B | -8.6B | -396M |
| Purchase of Investments | -23.66B | -113.08B | -178.82B | -185.05B | -154.76B | -238.59B | -161.09B | -251.85B | -251.47B | -536.08B |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Investing | 478M | -236M | -3.42B | -1.5B | -1.23B | -3.96B | 770M | 239M | 685M | -195M |
| Cash from Financing | 3.8B | 12.79B | -1.4B | -5.81B | 730M | -18.34B | -28.51B | -1.66B | -14.4B | -10.36B |
| Dividends Paid | -3.94B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -1.35B | -4.85B | -24.71B | -27.06B | -7.85B | -9.17B | -2.92B |
| Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | 1000K | 1000K | -1000K | -1000K | 1000K | 1000K | -1000K | 1000K | -1000K | -1000K |
| Other Financing | 3.71B | 112M | -121M | -343M | -497M | -429M | -695M | -1.98B | -4.15B | -5.62B |
| Net Change in Cash | 8.46B | -39.11B | 3.54B | -1.4B | 33.82B | -16.24B | 40.31B | -52.31B | 2.24B | 9.73B |
| Exchange Rate Effect | -1000K | -1000K | 1000K | -1000K | 1000K | 1000K | 1000K | -1000K | 1000K | -1000K |
| Cash at Beginning | 63.27B | 67.16B | 28.05B | 32.21B | 30.81B | 64.63B | 48.4B | 88.71B | 36.4B | 38.64B |
| Cash at End | 71.73B | 28.05B | 31.58B | 30.81B | 64.63B | 48.4B | 88.71B | 36.4B | 38.64B | 48.38B |
| Free Cash Flow | 15.41B | 19.58B | 34.07B | 22.86B | 22.71B | 26.76B | 26.14B | 21.76B | 29.79B | 11.62B |
| FCF Growth % | -0.08% | 0.27% | 0.74% | -0.33% | -0.01% | 0.18% | -0.02% | -0.17% | 0.37% | -0.61% |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - |
| FCF per Share | 6.25 | 7.94 | 13.81 | 9.27 | 9.27 | 11.19 | 11.54 | 9.88 | 13.71 | 5.39 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 83.43% | 84.93% | 90.15% | 98.22% | 68.62% | 80.55% | 68.47% | 113.03% | 72.65% | 84% |
| Medical Cost Ratio | 56.4% | 59.93% | 65.62% | 67.3% | 47.82% | 52.69% | 47.9% | 79.96% | 52.46% | 76.69% |
| Return on Equity (ROE) | 9.6% | 8.85% | 14.1% | 1.14% | 20.85% | 9.66% | 18.62% | -4.57% | 18.29% | 14.56% |
| Return on Assets (ROA) | 4.47% | 4.1% | 6.79% | 0.57% | 10.67% | 5.03% | 9.82% | -2.39% | 9.53% | 8% |
| Equity / Assets | 46.83% | 45.97% | 50.13% | 49.8% | 52.41% | 51.66% | 53.71% | 50.79% | 53.34% | 56.48% |
| Book Value / Share | 104.93 | 115.76 | 142.67 | 142.96 | 174.86 | 188.71 | 227.32 | 218.62 | 262.63 | 302.17 |
| Debt / Equity | 0.28x | 0.30x | 0.29x | 0.28x | 0.25x | 0.27x | 0.23x | 0.27x | 0.23x | 0.22x |
| Revenue Growth | 8.34% | 5.91% | 8.34% | -6.89% | 45.19% | -12.5% | 23.89% | -34% | 87.65% | -15.46% |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Berkshire Hathaway Insurance Group | 45.86B | 50.4B | 65.51B | 62.94B | 67.69B | 69.36B | 75.14B | 82.38B | 95.02B | 105.07B |
| Berkshire Hathaway Insurance Group Growth | - | 9.92% | 29.97% | -3.93% | 7.56% | 2.46% | 8.33% | 9.63% | 15.35% | 10.57% |
| Manufacturing Businesses | 36.14B | 46.51B | 50.45B | 61.88B | 62.73B | 59.08B | 68.73B | 75.78B | 75.41B | 77.23B |
| Manufacturing Businesses Growth | - | 28.70% | 8.47% | 22.67% | 1.37% | -5.82% | 16.34% | 10.26% | -0.50% | 2.42% |
| Mc Lane Company | 48.22B | 48.08B | 49.77B | 49.99B | 50.46B | 46.84B | 49.45B | 53.21B | 52.61B | 51.91B |
| Mc Lane Company Growth | - | -0.31% | 3.54% | 0.43% | 0.94% | -7.17% | 5.57% | 7.60% | -1.13% | -1.33% |
| Pilot Travel Centers ("Pilot) | - | - | - | - | - | - | - | - | 51.74B | 46.89B |
| Pilot Travel Centers ("Pilot) Growth | - | - | - | - | - | - | - | - | - | -9.37% |
| Service And Retailing Businesses | 23.47B | 25.48B | 26.31B | 28.94B | 29.49B | 28.18B | 34.83B | 38.3B | 40B | 39.87B |
| Service And Retailing Businesses Growth | - | 8.57% | 3.28% | 9.98% | 1.89% | -4.44% | 23.61% | 9.96% | 4.42% | -0.31% |
| Berkshire Hathaway Energy Company | 18.23B | 17.86B | 18.94B | 19.99B | 20.11B | 21.03B | 24.99B | 26.39B | 26.01B | 26.35B |
| Berkshire Hathaway Energy Company Growth | - | -2.04% | 6.05% | 5.53% | 0.64% | 4.56% | 18.81% | 5.63% | -1.46% | 1.31% |
| Burlington Northern Santa Fe Corporation | 21.97B | 19.83B | 21.39B | 23.86B | 23.52B | 20.87B | 23.28B | 25.89B | 23.88B | 23.57B |
| Burlington Northern Santa Fe Corporation Growth | - | -9.73% | 7.86% | 11.54% | -1.43% | -11.25% | 11.56% | 11.19% | -7.77% | -1.27% |
| Finance and Financial Products Reportable | 6.96B | 7.67B | 8.38B | - | - | - | - | - | - | - |
| Finance and Financial Products Reportable Growth | - | 10.21% | 9.13% | - | - | - | - | - | - | - |
Berkshire Hathaway Inc. (BRK-B) has a price-to-earnings (P/E) ratio of 11.9x. This may indicate the stock is undervalued or faces growth challenges.
Berkshire Hathaway Inc. (BRK-B) saw revenue decline by 15.5% over the past year.
Yes, Berkshire Hathaway Inc. (BRK-B) is profitable, generating $67.46B in net income for fiscal year 2024 (24.0% net margin).
Berkshire Hathaway Inc. (BRK-B) has a return on equity (ROE) of 14.6%. This is reasonable for most industries.
Berkshire Hathaway Inc. (BRK-B) has a combined ratio of 84.0%. A ratio below 100% indicates underwriting profitability.